Health Condition 1: E11- Type 2 diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age group patients of age 18-60 years 2.Patients of both sexes 3.Patients with HbA1c levels more than 7.0 percent 4.Patients with pre-diagnosed diabetes mellitus type2 5.Patients with FBS more than 140 mg per dL and PPBS more than 200 mg per dL 6.Patients who are not taking any anti-diabetic treatment for a minimum of 3 months from any system of medicine 7.Patient who is interested to take treatment on a regular basis with timely follow up can provide valid consent to participate in the study
Exclusion criteria
Exclusion criteria: 1.Patients suffering from other comorbid conditions like chronic tuberculosis, cancer, chronic kidney disease in addition to type 2 diabetes mellitus 2.Pregnant women with lactating mothers 3.Chronic liver disease patients 4.All other types of diabetes mellitus will be excluded 5.Other major systemic illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c-6 to 7 Good control HbA1C-7-8 Moderate control HbA1C- Above 8 Poor control Timepoint: 3 Months | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.It is expected that changes will be seen in QoL scale. Will be assessed at the baseline and at the completion of 3 months 2.It is expected that there will be reduction in FBS and PPBS levels after 3 months. Timepoint: 3 Months | — |
Countries
India
Contacts
The Calcutta Homoeopathic Medical College and Hospital